The Oligonucleotide Synthesis Market size was estimated to be US$ 7490.31 million in 2021 and US$ XX million in 2023 and is expected to reach US$ 42578.51 million by 2031; it is estimated to record a CAGR of 19.3% in till 2031.

The oligonucleotide synthesis market is growing rapidly, driven by advancements in genetic research, biotechnology, and personalized medicine. The demand for custom oligonucleotides in diagnostics, therapeutics, and drug discovery is rising. Market growth is further supported by the increasing applications of RNA-based therapies and genetic testing in healthcare.

Source: The Insight Partners